MiNK Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
INKT on Nasdaq
Location
149 Fifth Avenue, Suite 500, New York, NY

There are no Buy or Sell transactions made by insiders since 10/24/2024

MiNK Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Agenus Inc 10%+ Owner $22.6M Oct 12, 2023
Garo H. Armen Director $2.05M May 5, 2023
Ulf WIInberg Director $675K Sep 9, 2025
Brian Corvese Director $671K Sep 9, 2025
Jennifer Buell Chief Executive Officer $561K Sep 9, 2025
Barbara Ryan Director $288K Sep 9, 2025
Peter Behner Director $258K Sep 9, 2025
Robert Peter Kadlec Director $248K Sep 9, 2025
Christine Klaskin Treasurer $57.9K Oct 13, 2021
John Baldoni Director $42.8K Sep 1, 2023
Antonius van Dijk Chief Scientific Officer Jan 16, 2024
Walter Md Flamenbaum Director Oct 13, 2021

Recent Insider Transactions by Companies or Individuals for MiNK Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.